← Eichor
Study identifier: NCT07007338 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet

Condition: Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism  ·  Sponsor: Hospices Civils de Lyon

PhaseN/A
Planned participants20
Who can joinAll sexes, 3 Years to 17 Years
Healthy volunteersNo

About this study

Managing bone and mineral disorders associated with chronic kidney disease (CKD-MBD) in children is a complex task. Controlling parathyroid hormone (PTH) levels involves adjusting calcium intake, managing hyperphosphatemia, intensive dialysis, and considering specific therapies like active vitamin D analogues and cinacalcet. Cinacalcet, authorized in Europe since 2017 for children over 3 undergoing dialysis with secondary hyperparathyroidism (SHPT), has shown efficacy in reducing PTH levels. The 2019 guidelines call for its use with caution particularly to avoid hypocalcemia, in children with severe hyperparathyroidism despite optimized conventional treatments. In adults, cinacalcet has been found to reduce serum PTH, calcium, and phosphate levels, decrease the risk of vascular calcification, and have a positive effect on bone formation. This suggests that cinacalcet may slow the progression of cardiovascular calcifications. Additionally, Professor Shroff has introduced a non-invasive method for assessing bone calcium status by analyzing stable calcium isotope ratios in blood. This method would allow to determine whether a treatment such as cinacalcet has a positive influence on bone calcium balance, a key element in the management of CKD-MBD.

This description comes directly from the study's public registry record.

Talk to the study team

BACCHETTA Justine, MD  ·  0033427856178  ·  Justine.bacchetta@chu-lyon.fr

FLAMMIER Sacha, MD  ·  0033472681349  ·  Sacha.flammier@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (7)

Service de Pédiatrie CHU de BordeauxBordeaux, FranceRecruiting
Hôpital Femme Mère EnfantBron, FranceRecruiting
Service de pédiatrie multidisciplinaire CHU de MontpellierMontpellier, FranceRecruiting
Unité de néphrologie pédiatrique, Hôpital Archet 2, CHU de NiceNice, FranceRecruiting
Service de Néphrologie pédiatrique Hôpital Necker Enfants MaladesParis, FranceRecruiting
Service de Néphrologie - Transplantation - Hémodialyse pédiatrique Hôpital Robert DebréParis, FranceRecruiting
Service de pédiatrie 1 CHU HautepierreStrasbourg, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07007338